Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ADAP |
---|---|---|
09:32 ET | 1994 | 1.13 |
09:36 ET | 200 | 1.11 |
09:38 ET | 4324 | 1.13 |
09:41 ET | 100 | 1.1129 |
09:43 ET | 144 | 1.11 |
09:45 ET | 775 | 1.1042 |
09:50 ET | 12600 | 1.13 |
09:52 ET | 3177 | 1.16 |
09:54 ET | 100 | 1.16 |
09:56 ET | 2500 | 1.1401 |
09:57 ET | 850 | 1.15 |
10:01 ET | 5900 | 1.16 |
10:03 ET | 1200 | 1.17 |
10:06 ET | 4300 | 1.18 |
10:08 ET | 800 | 1.18 |
10:10 ET | 1650 | 1.18 |
10:12 ET | 400 | 1.18 |
10:14 ET | 300 | 1.18 |
10:15 ET | 200 | 1.18 |
10:17 ET | 2390 | 1.17 |
10:19 ET | 700 | 1.18 |
10:21 ET | 2875 | 1.18 |
10:24 ET | 200 | 1.18 |
10:26 ET | 3531 | 1.16 |
10:28 ET | 700 | 1.1605 |
10:30 ET | 500 | 1.1601 |
10:32 ET | 300 | 1.18 |
10:33 ET | 300 | 1.18 |
10:35 ET | 800 | 1.17 |
10:37 ET | 403 | 1.1691 |
10:42 ET | 2000 | 1.1604 |
10:50 ET | 100 | 1.17 |
10:51 ET | 950 | 1.161 |
10:53 ET | 200 | 1.17 |
10:55 ET | 300 | 1.17 |
10:57 ET | 200 | 1.17 |
11:00 ET | 200 | 1.17 |
11:02 ET | 1700 | 1.17 |
11:04 ET | 1950 | 1.165 |
11:06 ET | 500 | 1.165 |
11:13 ET | 3146 | 1.16 |
11:20 ET | 1523 | 1.15 |
11:22 ET | 1100 | 1.15 |
11:24 ET | 3550 | 1.15 |
11:26 ET | 20700 | 1.14 |
11:27 ET | 36087 | 1.17 |
11:29 ET | 100 | 1.17 |
11:31 ET | 6240 | 1.17 |
11:33 ET | 300 | 1.17 |
11:40 ET | 1582 | 1.1601 |
11:45 ET | 1100 | 1.17 |
11:47 ET | 200 | 1.175 |
11:49 ET | 100 | 1.175 |
11:51 ET | 2489 | 1.175 |
11:54 ET | 1400 | 1.18 |
11:56 ET | 200 | 1.18 |
11:58 ET | 1200 | 1.18 |
12:00 ET | 300 | 1.18 |
12:02 ET | 27335 | 1.18 |
12:03 ET | 200 | 1.185 |
12:05 ET | 1700 | 1.19 |
12:07 ET | 200 | 1.19 |
12:09 ET | 5320 | 1.19 |
12:12 ET | 500 | 1.19 |
12:18 ET | 1232 | 1.185 |
12:20 ET | 1100 | 1.19 |
12:23 ET | 500 | 1.1853 |
12:25 ET | 100 | 1.1907 |
12:27 ET | 300 | 1.2 |
12:32 ET | 6766 | 1.19 |
12:34 ET | 700 | 1.19 |
12:36 ET | 200 | 1.19 |
12:38 ET | 611 | 1.19 |
12:39 ET | 600 | 1.18 |
12:41 ET | 355 | 1.1801 |
12:43 ET | 5300 | 1.18 |
12:45 ET | 10706 | 1.17 |
12:50 ET | 3889 | 1.17 |
12:52 ET | 6054 | 1.1501 |
12:54 ET | 691 | 1.15 |
12:57 ET | 24583 | 1.14 |
01:01 ET | 100 | 1.145 |
01:03 ET | 100 | 1.14 |
01:10 ET | 300 | 1.14 |
01:12 ET | 10833 | 1.14 |
01:14 ET | 1000 | 1.1301 |
01:15 ET | 300 | 1.13 |
01:24 ET | 100 | 1.14 |
01:26 ET | 2626 | 1.14 |
01:28 ET | 200 | 1.145 |
01:30 ET | 200 | 1.145 |
01:32 ET | 200 | 1.145 |
01:33 ET | 200 | 1.145 |
01:35 ET | 100 | 1.145 |
01:37 ET | 100 | 1.145 |
01:39 ET | 700 | 1.15 |
01:42 ET | 790 | 1.15 |
01:44 ET | 100 | 1.15 |
01:46 ET | 200 | 1.15 |
01:48 ET | 200 | 1.15 |
01:50 ET | 200 | 1.15 |
01:51 ET | 980 | 1.15 |
01:53 ET | 1700 | 1.15 |
02:00 ET | 600 | 1.15 |
02:02 ET | 300 | 1.16 |
02:04 ET | 200 | 1.155 |
02:06 ET | 2897 | 1.16 |
02:08 ET | 400 | 1.16 |
02:09 ET | 300 | 1.16 |
02:11 ET | 200 | 1.16 |
02:13 ET | 200 | 1.16 |
02:15 ET | 6595 | 1.15 |
02:18 ET | 891 | 1.1594 |
02:20 ET | 2000 | 1.1423 |
02:24 ET | 100 | 1.14 |
02:33 ET | 100 | 1.15 |
02:36 ET | 20200 | 1.14 |
02:38 ET | 800 | 1.16 |
02:40 ET | 200 | 1.16 |
02:42 ET | 200 | 1.16 |
02:45 ET | 1300 | 1.16 |
02:47 ET | 4652 | 1.16 |
02:51 ET | 103 | 1.1589 |
02:54 ET | 281 | 1.16 |
02:56 ET | 18011 | 1.15 |
02:58 ET | 200 | 1.15 |
03:03 ET | 9819 | 1.1599 |
03:05 ET | 3000 | 1.151 |
03:07 ET | 700 | 1.17 |
03:09 ET | 4505 | 1.16 |
03:12 ET | 1178 | 1.1525 |
03:18 ET | 2000 | 1.155 |
03:20 ET | 100 | 1.16 |
03:21 ET | 200 | 1.17 |
03:23 ET | 500 | 1.16 |
03:25 ET | 200 | 1.15 |
03:27 ET | 500 | 1.17 |
03:30 ET | 800 | 1.16 |
03:32 ET | 3075 | 1.15 |
03:34 ET | 900 | 1.155 |
03:36 ET | 171 | 1.16 |
03:38 ET | 500 | 1.16 |
03:39 ET | 900 | 1.16 |
03:41 ET | 1300 | 1.16 |
03:43 ET | 700 | 1.16 |
03:45 ET | 800 | 1.16 |
03:48 ET | 2089 | 1.1501 |
03:50 ET | 1250 | 1.15 |
03:52 ET | 581 | 1.155 |
03:54 ET | 400 | 1.16 |
03:56 ET | 4000 | 1.155 |
03:57 ET | 10062 | 1.1569 |
03:59 ET | 17000 | 1.17 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Adaptimmune Therapeutics PLC | 286.2M | -2.2x | --- |
Poseida Therapeutics Inc | 256.4M | -2.0x | --- |
Innate Pharma SA | 196.8M | -25.8x | --- |
MacroGenics Inc | 207.1M | -11.7x | --- |
Codexis Inc | 255.4M | -3.8x | --- |
Enanta Pharmaceuticals Inc | 267.6M | -2.1x | --- |
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. The Company is focused on providing cell therapies to people with cancer. Its engineered T-cell receptor (TCR) platform enables the engineering of T-cells to target and destroy cancers across multiple solid tumor types. Its cell therapy candidates include TCR T-cells and TruC T-cells. Its product candidates include afamitresgene autoleucel (afami-cel) and Lete-cel. The afamicel is a cell therapy that provides a treatment option for people with synovial sarcoma. The Company is in the process of transitioning lete-cel, which targets the NY-ESO antigen in people with synovial sarcoma and myxoid round cell liposarcoma (MRCLS). Its clinical pipeline includes SURPASS-III Phase II Trial with ADP-A2M4CD8 and SURPASS Phase I Trial with ADP-A2M4CD8. The Company’s most advanced pre-clinical programs are for T-cell therapies directed to the PRAME target (ADP-600) and to CD70 (ADP-520). ADAP-600 is an engineered TCR T-cell.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $299.0M |
---|---|
Revenue (TTM) | $60.3M |
Shares Outstanding | 255.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.35 |
EPS | $-0.52 |
Book Value | $0.17 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -195.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.